Five times subsequent the principal outcome evaluation day. In addition to PTSD symptom improvement, the ketamine group exhibited markedly better reduction in comorbid depressive signs and symptoms when compared to the midazolam group, which is noteworthy given the high comorbidity of depression in individuals with PTSD. Research findings further prompt https://jeani666gwl5.blogproducer.com/profile